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Abstract 
The gene encoding the human homologue of the guinea pig uterine bombesm receptor [( 1992) Eur. J. Biochem. 208,405] was isolated from a genomic 
lambda library by the PCR/homology screening approach. The gene spans more than 4 kb and consists of 3 exons and 2 introns. The deduced amino 
acid sequence shows about 86% identity to that of guinea pig bombesin receptor. This subtype of bombesin receptor is expressed in the pregnant 
uterus and in two human tumour cell lines, T47D (ductal breast carcinoma) and A431 (epidermal carcinoma). PCR analysis of genomic DNA from 
human-mouse cell hybrids allows the cloned gene to be localized to the region q26q28 on chromosome X. 
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1. Introduction 
Bombesin isolated from frog skin in 1971 [l] gave the 
name to the large family of related regulatory peptides 
discovered later. More than 20 peptides of this family 
can be classified into three subfamilies according to their 
C-terminal tripeptide: bombesin, ranatensimlitorin and 
phyllolitorin subfamilies [2]. To date, only three bomb- 
esin-like peptides - gastrin-releasing peptide (GRP), its 
C-terminal decapeptide neuromedin C, and neuromedin 
B - were identified in mammals. The first two represent 
the bombesin subfamily, neuromedin B belongs to the 
ranatensimlitorin subfamily. No mammalian member of 
the phyllolitrin subfamily has been yet found. 
Bombesin-like peptides demonstrate a wide spectrum 
of biological activities in mammals, such as secretion of 
gut hormones, the regulation of smooth-muscle contrac- 
tion, the regulation of homeostasis and thermoregula- 
tion. They are involved in cell proliferation and act as 
autocrine growth factors for small-cell lung carcinoma 
[31. 
Bombesin-like peptides exert their effects via recep- 
tors, that can be distinguished based on binding studies 
as GRP-preferring and neuromedin-B-preferring recep- 
tors [4]. Both types of human and rodent receptors have 
been cloned and characterized [5-71. Recently we have 
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cloned a new bombesin receptor subtype from guinea pig 
that is expressed in uterus during pregnancy [8]. The 
similarity between this receptor and the two other cloned 
rodent bombesin receptors, the GRP receptor and the 
neuromedin B receptor, is 52% and 47%, respectively, i.e. 
lies in the range usually observed for receptor subtypes 
within the same family. The new receptor subtype binds 
GRP better than neuromedin B, but the low affinity of 
the binding (IC,, = 300 nM) does not allow to attribute 
this receptor to the GRP-subtype. 
In this paper we report the identification of the gene 
for a human homologue of this receptor, its molecular 
organization and chromosomal ocalization. 
2. Materials and methods 
Polymerase chain reaction (PCR) was carried out using human 
genomic DNA and degenerate oligonucleotides based on the bombesin 
receptor sequence from guinea pig. The PCR conditions were follow- 
ing: 30 cycles 94°C 1 min; 5O”C, 1.5 min; 72°C. 3 min. PCR products 
were resolved on agarose gel, transferred to Hybond-N and hybridized 
to the 3ZP-labelled 1.5-kb EcoRI-PstI fragment of PU61 clone [8]. 
Amplified DNA was cloned mto pGEM-7Zf(+) (Promega) and par- 
tially sequenced. The DNA insert of the clone with high homology to 
the bombesin receptor from guinea pig was used to screen a human 
placenta genomic library (Stratagene, Heidelberg). Phage DNA from 
one positive clone, HSUBR, was isolated and subjected to restriction 
analysis. DNA subfragments were isolated, recloned into pGEM- 
7Zf(+) or into pUC19 and sequenced on both strands by the dideoxynu- 
cleotide chain-termination method using a Sequenase version 2.0 kit 
(United States Biochemrcals) and utilizing universal and internal ol- 
igonucleotide primers. 
Most techniques, including Southern blotting, screening of phage 
library, plasmid and phage DNA isolation, recloning, were done by 
standard protocols [9]. 
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Human myometrium (3 probes at term, two from non-pregnant 
uterus) was obtained from surgical specimen with informed consent of 
the patients. For reverse transcription-polymerase chain reaction (RT- 
PCR) total RNA was isolated from frozen tissues or cells by the acid- 
guanidinium-isothiocyanate/phenol-chloroform method [lo] and 
mRNA was prepared using the PolyATtract mRNA Isolation system 
(Promeaa). Single-stranded cDNA was synthesized with Superscript 
reverse &kcri$ase (Gibco BRL), the template RNA was hydrolysed 
with NaOH and the cDNA was subiected to 30 cvcles PCR (94”C, 
1 min; 44”C, 2 min; 72”C, 3 min) wi& primers HBi 3 (S-ACTCAC- 
TACCTTGCAGAA-3’) and HBR 4 (S-TACATAGGTTTGAG- 
AAGT-3’) in the presence of 5% DMSO. The PCR product was analy- 
sed by Southern blot hybridization with the 32P-labelled 380-bp XbaI- 
ScaI fragment of HSUBR (exon 2). The PCR product was cloned into 
pGEM-T (Progema) and partially sequenced. 
For chromosomal localization of the human bombesin gene, 200 ng 
DNA from various somatic cell hybrids was subjected to PCR (30 
cycles 94”C, 1 min; 53V, 1.5 min; 72’C, 3 min) with the primers HBR 
1 (S-CTGGGAGCATACAGATGTC-3’) and HBR 2 (S-CCATTT- 
GACTTCCCTTACG-33. The experiments were done first on 14 
human-rodent somatic cell hybrids and then on cells, carrying different 
parts of the human X chromosome. The origin of the cell hybrids used 
in this study and their chromosome content have been described previ- 
ously [11,12]. 
3. Results and discussion 
Because our first experiments howed that it would be 
difficult to find a human tissue expressing this new sub- 
type of bombesin receptor, we decided to clone the 
genomic gene from a human genomic library. Southern 
blot analysis of guinea pig genomic DNA revealed that 
this bombesin receptor subtype like two others [7] con- 
tains introns (data not shown). We designed degenerate 
oligonucleotides for PCR based on the bombesin recep- 
tor cDNA sequence, taking into account that the amino 
acid sequence of the receptor in the position of the prim- 
ers should be most divergent within the bombesin recep- 
tor subfamily and at the same time enough conserved to 
be present in human species. One pair of oligonucleo- 
tides 5’-GGATAI,ATGTCC/,ATGATA/cTTT/,GC-3’ and 
5’-GT=IcACGIAATGAAAAIGTGGATGGC-3 (trans- 
membrane domains 4 and 7, respectively) gave after 
PCR on human genomic DNA a product that hybridized 
to a guinea pig bombesin receptor cDNA fragment. This 
PCR product (2.3 kb) was gel-purified and cloned into 
pGEM-7Zf(+). By partial sequencing aclone was identi- 
fied that contained a coding region for a bombesin recep- 
tor similar to the guinea pig receptor but different from 
two other cloned human bombesin receptors. The two 
parts of the receptor coding region were separated by a 
large intron. Using the cloned PCR product as a 
“P-probe we screened 500,000 recombinant phage from 
a human placenta genomic library. One positive clone, 
HSUBR, was identified, its DNA was isolated and sub- 
jected to restriction analysis. The fragments of the large 
insert were recloned then into pGEM-7Zf(+) or pUC19 
and sequenced on both strands (Fig. 1). 
The comparison of the cloned human bombesin recep- 
tor with other bombesin receptors allowed to localize the 
start and end of the coding region and to suggest he 
position of exon-intron boundaries. The last could be 
proved only by cDNA analysis. For this purpose we 
applied RT-PCR approach with two HSUBR-specific 
oligonucleotides designed to the sequences within exons 
1 and 3 (see Section 2). Using RT-PCR and Southern 
blotting of PCR products we observed the fragment of 
expected size (591 bp) in human pregnant myometrium 
as well as in two human cell lines, T47D (ductal breast 
carcinoma) and A431 (epidermal carcinoma) (Fig. 2). 
The cloning and partial sequencing of the PCR product 
confirmed that these cell lines and human pregnant 
myometrium do express bombesin receptor. The se- 
quence data showed the exact position of introns in the 
bombesin receptor gene. Intron 1 interrupts the codon 
for Arg’45; intron 2 is located between codons for Glr?’ 
and Ile263. These positions coincide with that in the two 
other bombesin receptor subtypes [7]. Every intron has 
a size of about 1.5 kb and the exon-intron boundaries 
fit well to the consensus plicing signal [13]. 
The comparison of the predicted amino acid sequence 
of HSUBR with that of the guinea pig bombesin receptor 
(Fig. 3) shows 86% overall identity. Even N-terminal 
regions of these receptors have 89% identity. The most 
divergent parts are their C-terminal regions. Neverthe- 
less, all potential phosphorylation sites present in the 
guinea pig bombesin receptor are conserved in the 
human homologue too. 
Due to the low level of bombesin receptor expression 
in the tested cell lines and tissues we could not determine 
the transcription initiation site in this gene. We have 
sequenced more than 1 kb upstream from the first ATG 
codon in the coding region (Fig. 1) and tried to localize 
the promotor elements using computer analysis by the 
PC-gene program EUKPROM. Several TATA-boxes 
were identified, but none of them contained a paired 
CAAT-box element and a cap signal. Some other G- 
protein-coupled receptors also lack TATA-box se- 
quences or paired TATA/CAAT elements in their pro- 
moter region [14,15]. But all these receptors have a high 
G + C content upstream from the translation initiation 
site and this feature resembles the promoters of ‘house- 
keeping genes’ [16]. In our case, however, the 5’ flanking 
sequence of HSUBR is rather A/T rich, there are no 
remarkable SP,-binding motifs [17], thus it is still un- 
clear, how and where the HSUBR gene transcription is 
initiated. 
The Southern blot analysis of human genomic DNA 
indicated that there is only one copy of this gene in the 
genome (data not shown). To localize the receptor gene 
on a chromosome we carried out the PCR analysis on 
chromosomal DNA from 14 human-rodent somatic cell 
hybrids [l l] using two HSUBR-specific primers (see Sec- 
tion 2). The primers were designed to the C-terminal part 
of the receptor and to the 3’ non-coding region, to re- 
gions where there is the highest difference between 
HSUBR and two other human bombesin receptor genes 
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Fig. 1. Genomic organisation of the human bombesin receptor gene HSUBR. (A) Schematic represensation of the HSUBR gene. The coding region 
is shown by closed boxes. The sites for translation initiation (ATG) and termination (TAG) are indicted. Xo, XhoI; E, EcoRI; X, Xbal; P, PslI; H, 
HindIII; C, CM; B, BurnHI. (B) Nucleotide and deduced amino acid sequence of HSUBR. 5’- and 3’-flanking regions and introns indicted by lower 
case letters. TATA-boxes in the 5’-flanking region found by computer analysis are underlined. 
[7], from one side, and also between HSUBR and PU18 
[8], from the other side. In control PCR experiments with 
chromosomal DNA from human cell lines a single 349 
bp fragment was observed. The mouse and Chinese ham- 
ster cells produced also PCR products, but these frag- 
ments had another size (1,060 and 900 bp, respectively) 
and did not disturb the interpretation of results. In the 
panel the human specific band segregated with the 
human X chromosome. All other human chromosomes 
could be excluded by their segregation pattern. A num- 
ber of the panel clones had been generated with cells 
from human X autosome translocation carriers that re- 
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Fig. 2. Analysis of bombesin receptor mRNA expression. RT-PCR 
products were analysed by Southern blotting (see Section 2). mRNA 
was prepared from mammocarcinoma cell lines (MCF7, T47D, 
SKBR3), epidermal carcinoma (A431), ovary carcinoma 0VCA3 
(OVC), HeLa, from pregnant myometrium (G), non-pregnant myomet- 
rium (NG) and placenta (P). Arrow indicates the expected 591-bp 
fragment. 
tained only part of this chromosome (Fig. 4). In these 
clones the smallest region of overlap (SRO) for the segre- 
gation of the human specific PCR fragment was the re- 
gion Xq26-28. These data indicate that the bombesin 
receptor gene HSUBR is located in a well studied region 
of the human X chromosome hosting among other genes 
the y-aminobutyric acid A receptor ~13 (GABRA 3), the 
arginine vasopressin V, receptor (AVPR2), a gene for 
spastic paraplegia 1 (SPGl), for myotubular myopathy 
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Fig. 3. Amino acid sequence alignment of guinea pig uterine bombesin 
receptor (PU 18) and HSUBR. Identical residues are shown by vertical 
lines. Putative transmembrane domains are overlined. 
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Fig. 4. PCR analysis of DNA from human-mouse somatic cell hybrids 
containing different fragments of the human X chromosome. The lines 
indicate which part of the X chromosome is retained in the individual 
clones used for PCR with primers HBRl and HBR2. Presence or 
absence of the HSUBR-specific PCR product is indicated by + or -. 
SRO, the smallest region of overlap. 
1 (MTMl), for Emery-Dreifuss muscular distrophy 
(EMD) and for Pettigrew syndrome [18]. 
In conclusion, we have cloned the gene for the human 
homologue of the guinea pig uterine bombesin receptor, 
determined its genomic organisation and localized this 
gene on the long arm of the human X chromosome. 
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